Cytomegalovirus Retinitis and Acquired Immunodeficiency Syndrome

Archives of Ophthalmology

Volumn 107, Issue 1, 1989, Pages 75-80

  Jabs, Douglas A ^a   Enger, Cheryl ^a   Bartlett, John G ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CYTOMEGALOVIRUS; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PRIORITY JOURNAL; RETINITIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ACYCLOVIR; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GANCICLOVIR; HUMAN; MALE; MIDDLE AGE; RETINAL DETACHMENT; RETINITIS; SUPPORT, U.S. GOV'T, P.H.S.; VISUAL ACUITY;

EID: 0024495240     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archopht.1989.01070010077031     Document Type: Article

References (29)

1. Holland GN, Gottlieb MS, Yee RD, et al: Ocular disorders associated with a new severe acquired cellular immunodeficiency syndrome. Am J Ophthalmol 1982;93:393-402.
2. Newman NM, Mandel MR, Gullett J, et al: Clinical and histologic findings in opportunistic infections. Arch Ophthalmol 1983;101:396-401.
3. Holland GN, Pepose JS, Pettit TH, et al: Acquired immune deficiency syndrome. Ophthalmology 1983;90:859-873.
4. Rosenberg PR, Uliss AE, Friedland GH, et al: Acquired immunodeficiency syndrome. Ophthalmology 1983;90:874-878.
5. Khadem M, Kalish SB, Goldsmith JA, et al: Ophthalmologic findings in acquired immune deficiency syndrome (AIDS). Arch Ophthalmol 1984;102:201-206.
6. Freeman WR, Lerner CW, Mines JA, et al: A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome. Am J Ophthalmol 1984;97:133-142.
7. Newsome DA, Green WR, Miller ED, et al: Microvascular aspects of acquired immune deficiency syndrome retinopathy. Am J Ophthalmol 1984;98:590-601.
8. Palestine AG, Rodrigues MM, Macher AM, et al: Ophthalmic involvement in acquired immunodeficiency syndrome. Ophthalmology 1984;91:1092-1099.
9. Pepose JS, Holland GN, Nestor MS, et al: Acquired immune deficiency syndrome. Ophthalmology 1985;92:472-484.
10. Kestelyn P, Van de Perre P, Rouvroy D, et al: A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome in Africa. Am J Ophthalmol 1985;100:230-238.
11. Schuman JS, Orellana J, Friedman AH, et al: Acquired immunodeficiency syndrome (AIDS). Surv Ophthalmol 1987;31:384-410.
12. Felsenstein D, D'Amico DJ, Hirsch MS, et al: Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine. Ann Intern Med 1985;103:377-380.
13. Palestine AG, Stevens G, Lane HC, et al: Treatment of cytomegalovirus retinitis with dihydroxy propoxymethyl guanine. Am J Ophthalmol 1986;101:95-101.
14. Collaborative DHPG Treatment Study Group: Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl) guanine in patients with AIDS and other immunodeficiencies. N Engl J Med 1986;314:801-805.
15. Rosecan LR, Stahl-Bayliss CM, Kalman CM, et al: Antiviral therapy for cytomegalovirus retinitis in AIDS with dihydroxy propoxymethyl guanine. Am J Ophthalmol 1986;101:405-418.
16. Jabs DA, Wingard JR, de Bustros S, et al: BW B759U for cytomegalovirus retinitis: Intraocular drug penetration. Arch Ophthalmol 1986;104:1436-1437.
17. Holland GN, Sakamoto MJ, Hardy D, et al: Treatment of cytomegalovirus retinopathy in patients with acquired immunodeficiency syndrome: Use of the experimental drug 9-[2hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine. Arch Ophthalmol 1986;104:1794-1800.
18. D'Amico DJ, Talamo JH, Felsenstein D, et al: Ophthalmoscopic and histologic findings in cytomegalovirus retinitis treated with BWB759U. Arch Ophthalmol 1986;104:1788-1793.
19. Henderly DE, Freeman WR, Causey DM, et al: Cytomegalovirus retinitis and response to therapy with ganciclovir. Ophthalmology 1987;94:425-434.
20. Holland GN, Sidikaro Y, Kreiger AE, et al: Treatment of cytomegalovirus retinopathy with ganciclovir. Ophthalmology 1987;94:815-823.
21. Jabs DA, Newman C, de Bustros S, et al: Treatment of cytomegalovirus retinitis with ganciclovir. Ophthalmology 1987;94:824-830.
22. Orellana J, Teich SA, Friedman AH, et al: Combined short- and long-term therapy for the treatment of cytomegalovirus retinitis using ganciclovir (BW B759U). Ophthalmology 1987;94:831-838.
23. Laskin OL, Cederberg DM, Mills J, et al: Ganciclovir for the treatment and suppression of serious infections caused by cytomegalovirus. Am J Med 1987;83:201.
24. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987;36:1S-15S.
25. Lee ET: Statistical Methods for Survival Data Analysis. Belmont, Calif, Lifetime Learning Publications, 1980, pp 21, 144.
26. Fischl MA, Richman DD, Grieco MH, et al: The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: A double-blind, placebo-controlled trial. N Engl J Med 1987;317:185-191.
27. Richman DD, Fischl MA, Grieco MH, et al: The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: A double-blind, placebo-controlled trial. N Engl J Med 1987;317:192-197.
28. Henderly DE, Freeman WR, Smith RE, et al: Cytomegalovirus retinitis as the initial manifestation of the acquired immune deficiency syndrome. Am J Ophthalmol 1987;103:316-320.
29. Freeman WR, Henderly DE, Wan WL, et al: Prevalence, pathophysiology, and treatment of rhegmatogenous retinal detachment in treated cytomegalovirus retinitis. Am J Ophthalmol 1987;103:527-536.